A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer
Clinical trial NCT02773524 · UNKNOWN
Trial details
- NCT number
- NCT02773524
- Sponsor
- Australasian Gastro-Intestinal Trials Group
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2022-01-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.